Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation TCT 2020

TCT 109: One-Year Outcomes With Lotus Edge: The REPRISE III Nested Registry

Presenter: Robert Gooley

October 14, 2020

Presentation TCT 2020

TCT 086: Transcatheter Aortic Valve Replacement With the LOTUS Edge System: Early European Experience

Presenter: Xavier Armario

October 14, 2020

Presentation TCT 2019

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Presenter: Kendra Grubb

September 27, 2019

Presentation TCT 2019

Real-World Experience of the LOTUS Edge Valve

Presenter: Hemal Gada

September 27, 2019

Presentation TCT 2019

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

Presenter: Thomas Pilgrim

September 27, 2019

Presentation TCT 2019

ACURATE neo: Features and Benefits for Optimized TAVR

Presenter: Helge Möllmann

September 27, 2019

Presentation TCT 2018

Program Update: The LOTUS TAVR System

Presenter: Michael J. Reardon

September 22, 2018

Presentation TCT 2018

TCT-14: Final 5-Year Outcomes Of The REPRISE II Study: Long-Term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve

Presenter: Charles J. Davidson, Jeffrey J. Popma, Nicolas Dumontiel

September 21, 2018

Presentation TCT 2017

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

Presenter: Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Presenter: Michael J. Reardon

October 31, 2017

Presentation TCT 2017

Case #7: Transapical Mitral ViMAC With Lotus (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Christopher U. Meduri

October 30, 2017

Presentation TCT 2017

Case #3: Transapical Mitral ViV With Lotus (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Vinayak Bapat

October 30, 2017

Presentation TCT 2016

TCT 1606: Transcatheter Transapical Mitral Valve-in-Valve Implantation for Bioprosthetic Valve Dysfunction Using a Lotus Valve System

Presenter: Massimo Napodano, Alfredo E. Rodriguez, Oscar Millan-Iturbe

November 01, 2016

Presentation TCT 2016

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Ted Feldman

November 01, 2016

Presentation TCT 2016

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

Presenter: Lutz Buellesfeld, Raj Makkar, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Chris Meduri

October 30, 2016

Presentation TCT 2015

FDA-Approved or US IDE Studies: LOTUS Procedural Considerations and Case Examples

Presenter: Ariel Finkelstein, Ganesh Manoharan, Ted E. Feldman

October 14, 2015

Presentation TCT 2014

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Presenter: Ian T. Meredith

September 15, 2014

Presentation TCT 2014

Lotus Valve - Technology Review and Status of the US Clinical Trial

Presenter: Ted E. Feldman

September 15, 2014

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

Advertisement

TCT 109: One-Year Outcomes With Lotus Edge: The REPRISE III Nested Registry

TCT 086: Transcatheter Aortic Valve Replacement With the LOTUS Edge System: Early European Experience

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Real-World Experience of the LOTUS Edge Valve

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

ACURATE neo: Features and Benefits for Optimized TAVR

Program Update: The LOTUS TAVR System

TCT-14: Final 5-Year Outcomes Of The REPRISE II Study: Long-Term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Case #7: Transapical Mitral ViMAC With Lotus (With Discussion)

Case #3: Transapical Mitral ViV With Lotus (With Discussion)

TCT 1606: Transcatheter Transapical Mitral Valve-in-Valve Implantation for Bioprosthetic Valve Dysfunction Using a Lotus Valve System

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

FDA-Approved or US IDE Studies: LOTUS Procedural Considerations and Case Examples

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Lotus Valve - Technology Review and Status of the US Clinical Trial

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content